Astec LifeSciences Limited (NSE:ASTEC)
625.75
-1.85 (-0.29%)
Mar 9, 2026, 3:30 PM IST
Astec LifeSciences Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 13,943 | 13,243 | 20,932 | 27,154 | 34,391 | 19,653 | Upgrade
|
| Market Cap Growth | -16.01% | -36.73% | -22.91% | -21.04% | 74.99% | 158.64% | Upgrade
|
| Enterprise Value | 17,519 | 18,229 | 25,222 | 29,616 | 36,253 | 20,638 | Upgrade
|
| Last Close Price | 625.75 | 670.36 | 1059.72 | 1373.40 | 1739.29 | 993.57 | Upgrade
|
| PE Ratio | - | - | - | 106.22 | 38.27 | 30.21 | Upgrade
|
| PS Ratio | 3.41 | 3.47 | 4.56 | 4.32 | 5.08 | 3.52 | Upgrade
|
| PB Ratio | 3.37 | 5.64 | 5.67 | 6.47 | 8.67 | 6.35 | Upgrade
|
| P/TBV Ratio | 3.58 | 6.27 | 5.98 | 6.73 | 8.93 | 6.46 | Upgrade
|
| P/OCF Ratio | - | - | 204.79 | 36.37 | 145.70 | - | Upgrade
|
| EV/Sales Ratio | 4.28 | 4.78 | 5.50 | 4.71 | 5.36 | 3.69 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | 39.00 | 23.60 | 18.02 | Upgrade
|
| EV/EBIT Ratio | - | - | - | 68.15 | 30.13 | 23.00 | Upgrade
|
| Debt / Equity Ratio | 0.89 | 2.36 | 1.34 | 0.81 | 0.70 | 0.61 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | 4.47 | 1.81 | 1.63 | Upgrade
|
| Net Debt / Equity Ratio | 0.86 | 2.36 | 1.34 | 0.81 | 0.70 | 0.60 | Upgrade
|
| Net Debt / EBITDA Ratio | -81.77 | -8.27 | -80.19 | 4.49 | 1.82 | 1.63 | Upgrade
|
| Net Debt / FCF Ratio | - | -18.33 | -3.94 | -8.00 | -3.47 | -1.69 | Upgrade
|
| Asset Turnover | - | 0.41 | 0.47 | 0.67 | 0.86 | 0.89 | Upgrade
|
| Inventory Turnover | - | 1.72 | 1.32 | 1.69 | 2.68 | 3.04 | Upgrade
|
| Quick Ratio | - | 0.41 | 0.43 | 0.30 | 0.57 | 0.59 | Upgrade
|
| Current Ratio | - | 0.93 | 1.00 | 0.95 | 1.05 | 1.02 | Upgrade
|
| Return on Equity (ROE) | - | -44.57% | -11.88% | 6.27% | 25.46% | 23.40% | Upgrade
|
| Return on Assets (ROA) | - | -7.40% | -2.66% | 2.90% | 9.55% | 8.98% | Upgrade
|
| Return on Invested Capital (ROIC) | -6.86% | -13.31% | -5.13% | 4.43% | 15.24% | 15.58% | Upgrade
|
| Return on Capital Employed (ROCE) | - | -21.30% | -7.20% | 9.60% | 29.60% | 25.20% | Upgrade
|
| Earnings Yield | -6.40% | -10.18% | -2.24% | 0.94% | 2.61% | 3.31% | Upgrade
|
| FCF Yield | - | -2.28% | -5.99% | -1.57% | -2.34% | -5.63% | Upgrade
|
| Dividend Yield | - | - | 0.14% | 0.11% | 0.09% | 0.15% | Upgrade
|
| Payout Ratio | - | - | - | 11.50% | 3.27% | 4.51% | Upgrade
|
| Buyback Yield / Dilution | -5.75% | -0.01% | -0.02% | -0.04% | -0.05% | -0.09% | Upgrade
|
| Total Shareholder Return | -5.75% | -0.01% | 0.13% | 0.07% | 0.04% | 0.07% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.